New CDC Study Slated To Assess PFAS Effects On COVID Vaccine Efficacy

December 14, 2020
The Centers for Disease Control and Prevention (CDC) has launched a series of studies to assess the excess risks from the coronavirus faced by those exposed to per- and polyfluoroalkyl substances (PFAS), including a new study of healthcare workers and first responders that could help determine vaccine efficacy and duration just as the first vaccines are poised for approval. Robert Redfield, director of the CDC and of the Agency for Toxic Substances and Disease Registry (ATSDR), told Rep. Dan Kildee...

Not a subscriber? Sign up for 30 days free access to exclusive environmental policy reporting.